Research programme: skin disorder topical therapeutics - Foamix

Drug Profile

Research programme: skin disorder topical therapeutics - Foamix

Alternative Names: Benzoyl peroxide foam - Foamix; Betamethasone dipropionate foam - Foamix; Calcipotriene foam - Foamix; Calcipotriol foam - Foamix; Ciclopirox foam - Foamix; Ciclopiroxolamine foam - Foamix; Clobetasol propionate foam - Foamix; Lactic acid/urea foam - Foamix; Salicylic acid foam - Foamix; Triamcinolone acetonide foam - Foamix; U-LAC foam; UFoam; Urea foam - Foamix; Urea/lactic acid foam - Foamix

Latest Information Update: 08 Oct 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Foamix
  • Developer Foamix; Therapeutics Incorporated
  • Class Benzoic acids; Corticosteroids; Cyclohexanes; Dihydroxycholecalciferols; Fluorinated steroids; Glucocorticoids; Hydroxy acids; Indenes; Lactates; Oxidants; Pregnadienes; Pyridones; Salicylates; Small molecules; Urea compounds; Vitamin D analogues
  • Mechanism of Action Calcitriol receptor agonists; Cytokine inhibitors; Glucocorticoid receptor agonists; Matrix metalloproteinase inhibitors; Mitosis inhibitors; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Acne; Atopic dermatitis; Dermatomycoses; Dry skin; Psoriasis; Seborrhoeic dermatitis
  • No development reported Hyperhidrosis

Most Recent Events

  • 08 Oct 2014 FDX 104 (doxocycline foam) enters clinical development for exanthema (chemotherapy-induced) in Israel (Topical)
  • 02 Jul 2014 Foamix's skin disorder topical therapeutics are available for licensing. http://www.foamix.co.il
  • 02 Jul 2014 No development reported for Hyperhidrosis in Israel (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top